-
Acute Heart Failure Market to Witness Upsurge in Growth, Examine DelveInsight | Key Companies in the Domain - AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Idorsia, Bristol-Myers Squibb, Novartis, Trevena, Scios
02 May 2023 17:00 GMT
… Squibb, Novartis, Trevena, Scios The acute heart failure … Nile Therapeutics, Trevena Inc., Scios, Inc., Novartis, and others … Bristol-Myers Squibb
Nesiritide: Scios, Inc.
LCZ696: Novartis
… Nile Therapeutics, Trevena Inc., Scios, Inc., Novartis, and others …
-
Global Acute Decompensated Heart Failure (ADHF) Market Spotlight 2019: Bayer Leads Industry Sponsors with the Highest Number of Clinical Trials, Followed by Scios - ResearchAndMarkets.com
27 Jun 2019 12:34 GMT
… trials for ADHF, followed by Scios.
Key Topics Covered:
OVERVIEW
KEY …
-
BioChromatographix International Officially Launches in Singapore
05 May 2025 19:36 GMT
… Abbott, Chiron (now Novartis), and Scios (now J&J).
He …
-
Scottish charity audit threshold to rise from £500,000 to £1m
27 Mar 2025 16:03 GMT
… deal with the issue of SCIOs that are breaching their duty …
-
Audit threshold for Scottish charities set to rise
27 Mar 2025 07:43 GMT
… deal with the issue of SCIOs that are breaching their duty …
-
Congestive Heart Failure Market Predicted to See Upsurge Through 2034, Highlights DelveInsight
21 Jan 2025 19:40 GMT
… AstraZeneca, GlaxoSmithKline, Otsuka Pharma, Scios, Inc., Janssen Pharma, Pharmacosmos … • tolvaptan: Otsuka Pharma
• nesiritide: Scios, Inc.
• Nesiritide: Janssen Pharma
… AstraZeneca, GlaxoSmithKline, Otsuka Pharma, Scios, Inc., Janssen Pharma, …
-
Endobronchial Valves Help Advanced COPD and Emphysema Patients Breathe Easier
11 Dec 2024 20:59 GMT
… Medical Technologies, Nycomed Salutar, and Scios Inc. He holds a PhD …
-
An Open Good Riddance Letter to FDA Commissioner Califf
28 Nov 2024 00:42 GMT
… from Amylin, Johnson & Johnson, Scios, Merck/Schering-Plough, Schering …